U.S., Sept. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07797855) titled 'A Study to See How Safe a New Medicine (NNC0705-0002) is in Healthy People' on Aug. 27.
Brief Summary: This study is testing NNC0705-0002, a new medicine that is being developed for conditions where inflammation may contribute to heart and metabolic health problems. The purpose of this study is to assess the safety, tolerability, pharmacokinetics, target engagement, and metabolism of NNC0705-0002 after single and multiple doses in healthy adults. NNC0705-0002 or a placebo (a substance that looks like the study medicine but contains no active medicine), and the treatment they receive may be chosen by chance. NNC0705-0002 is a new med...